SYN - Synthetic Biologics' (SYN) CEO Steven Shallcross on Q2 2020 Results - Earnings Call Transcript
Synthetic Biologics, Inc. (SYN)
Q2 2020 Earnings Conference Call
August 6, 2020, 04:30 PM ET
Company Participants
Vincent Perrone - Director, Corporate Communication
Steven Shallcross - CEO, CFO, Treasurer and Secretary, Director
Michael Kaleko - SVP of R&D
Conference Call Participants
James Molloy - Alliance Global Partners
Michael Okunewitch - Maxim Group
Presentation
Operator
Good afternoon and welcome to the Synthetic Biologics' 2020 Second Quarter Investor Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded.
At this time, I would like to turn the call over